| NCT ID | NCT07558109 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 478 participants |
| Start Date | 2025-02-14 |
| Primary Completion | 2027-02-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 478 participants in total. It began in 2025-02-14 with a primary completion date of 2027-02-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Eligible patients will be interviewed by research staff to explain the trial design and rationale. Written informed consent will be obtained from patients who voluntarily agree to participate. Demographics and medical history will be obtained. A 12-lead ECG will be performed; it has not been performed within 6 months. A photo of the 12-lead ECG will be taken by research staff using the DigitHeart-2 smartphone application. Predictions from DigitHeart-2/MERL-ECHO and other machine learning models hosted by the investigator team for each of the target anatomical and mechanical properties will be recorded. The cardiologist in charge of the patient, who is blinded to the prediction results from DigitHeart-2/MERL-ECHO, will perform echocardiography according to American Society of Echocardiography guidelines, which will serve as the gold standard for accuracy evaluation.
Eligibility Criteria
Inclusion Criteria: * aged ≥ 18 years old * planned to have echocardiography performed * voluntarily agree to participate in the trial. Exclusion Criteria: * had echocardiography performed within 1 month * pacemaker rhythm on ECG * dextrocardia * complex adult congenital heart disease * ventricular assist device implantation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07558109 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07558109 currently recruiting?
Yes, NCT07558109 is actively recruiting participants. Contact the research team at wongeck@hku.hk for enrollment information.
Where is the NCT07558109 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07558109 clinical trial?
NCT07558109 is sponsored by The University of Hong Kong. The trial plans to enroll 478 participants.